Cervical Cytopathology

Cervical cytology became the standard screening test for cervical cancer and premalignant cervical lesions. Cytologic examinations may be performed on body fluids (examples are blood, urine, and cerebrospinal fluid) or on material that is aspirated (drawn out via suction into a syringe) of the body. Cytology also can involve examinations of preparations that are scraped or washed (irrigated with a sterile solution) from specific areas of the body. For example, a common example of diagnostic cytology is the evaluation of cervical smears (referred to as the Papanicolaou test or Pap smear).

There are several methods to screen for cervical cancer. The Pap test (also known as Pap smear or conventional cytology) and liquid-based cytology are widely used throughout the world and have been credited with greatly reducing the number of cases and mortality from cervical cancer in the developed world. Cytology-based tests have not been as effective in developing countries, leading to an investigation of cervical screening approaches more suited to low-resource settings such as visual inspection with acetic acid or HPV DNA testing.

    Related Conference of Cervical Cytopathology

    March 20-21, 2019

    International Conference on Molecular Pathology

    Paris | France
    April 22-23, 2019

    16th Annual Conference on Laboratory Medicine & Pathology

    Kuala Lumpur, Malaysia
    May 9-10, 2019

    17th European Pathology Congress

    | Amsterdam, Netherlands
    June 28-29, 2019

    Breast Pathology 2019

    Oslo, Norway
    July 29-30, 2019

    17th Asia Pacific Pathology Congress

    Mercure Albert Park, Melbourne, Australia
    November 08 09, 2019

    18th Global Congress on Pathology

    San Francisco | California | United States
    November 19-20, 2019

    2nd European Pathology and Infectious Disease Conference

    Helsinki, Finland

    Cervical Cytopathology Conference Speakers